
Amryt Pharma plc AMYT
Amryt Pharma plc Operating Expenses | AMYT
Annual Operating Expenses Amryt Pharma plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 109 M | 52.2 M | 27.9 M | 25.9 M | 6.95 M | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 109 M | 6.95 M | 44.4 M |
Operating Expenses of other stocks in the Biotechnology industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Albireo Pharma
ALBO
|
163 M | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
265 M | - | - | $ 546 M | ||
|
Landos Biopharma
LABP
|
22.7 M | - | 0.58 % | $ 144 M | ||
|
CASI Pharmaceuticals
CASI
|
61.3 M | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
64.6 M | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
56.6 M | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
50 M | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
156 M | - | - | $ 127 M | ||
|
Aravive
ARAV
|
80 M | - | -13.39 % | $ 1.45 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
61.5 M | - | - | $ 231 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
340 M | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
24.6 M | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
13.5 B | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
84.4 M | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
137 M | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
269 M | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
19.4 M | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
153 M | - | - | $ 58.1 M | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
55.7 M | - | -14.27 % | $ 1.7 M | ||
|
Adverum Biotechnologies
ADVM
|
140 M | - | - | $ 86.2 M | ||
|
BELLUS Health
BLU
|
77.9 M | - | - | $ 2.47 B | ||
|
Intra-Cellular Therapies
ITCI
|
228 M | - | - | $ 13.6 B | ||
|
Marinus Pharmaceuticals
MRNS
|
69.7 M | - | - | $ 29.6 M | ||
|
GeoVax Labs
GOVX
|
4.44 M | $ 1.83 | -4.45 % | $ 8.35 M | ||
|
Unity Biotechnology
UBX
|
31.2 M | - | -33.41 % | $ 3.37 M | ||
|
Applied Molecular Transport
AMTI
|
127 M | - | - | $ 10.1 M | ||
|
Tyme Technologies
TYME
|
25.5 M | - | 8.07 % | $ 54 M | ||
|
Karuna Therapeutics
KRTX
|
495 M | - | - | $ 12.2 B | ||
|
Revance Therapeutics
RVNC
|
317 M | - | - | $ 309 M | ||
|
Aptinyx
APTX
|
62.6 M | - | -39.0 % | $ 4.57 M | ||
|
TRACON Pharmaceuticals
TCON
|
21.3 M | - | -1.38 % | $ 46.8 M | ||
|
Forward Pharma A/S
FWP
|
3.87 M | - | -0.75 % | $ 18.7 M | ||
|
9 Meters Biopharma
NMTR
|
42 M | - | -42.97 % | $ 1.05 M | ||
|
Theratechnologies
THTX
|
77.7 M | - | - | $ 83.9 M | ||
|
Allena Pharmaceuticals
ALNA
|
10.1 M | - | 3.16 % | $ 1.9 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
247 M | - | -15.15 % | $ 60.3 M | ||
|
TFF Pharmaceuticals
TFFP
|
22.6 M | - | -60.05 % | $ 125 K | ||
|
Codiak BioSciences
CDAK
|
92.5 M | - | -55.98 % | $ 2.15 M | ||
|
Sage Therapeutics
SAGE
|
474 M | - | - | $ 527 M | ||
|
Paratek Pharmaceuticals
PRTK
|
114 M | - | - | $ 121 M | ||
|
AVEO Pharmaceuticals
AVEO
|
21.8 M | - | - | $ 521 M | ||
|
Cyclerion Therapeutics
CYCN
|
3.21 M | $ 34.99 | 3.77 % | $ 147 M | ||
|
Seelos Therapeutics
SEEL
|
42.7 M | - | -47.76 % | $ 6.27 M | ||
|
Завод ДИОД
DIOD
|
249 M | - | - | - | ||
|
Kiromic BioPharma
KRBP
|
23.8 M | - | 6.61 % | $ 3.08 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
226 M | - | - | $ 2.18 B | ||
|
Fusion Pharmaceuticals
FUSN
|
101 M | - | - | $ 1.41 B | ||
|
Gritstone Oncology
GRTS
|
156 M | - | 0.42 % | $ 213 M | ||
|
Aridis Pharmaceuticals
ARDS
|
23.4 K | - | 17.91 % | $ 11.1 M |